136 related articles for article (PubMed ID: 8221168)
1. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol.
Dagnault A; Ouerghi D; Richard D
Brain Res Bull; 1993; 32(6):689-92. PubMed ID: 8221168
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
Swerdlow NR; Britton KT; Koob GF
Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of alpha-adrenergic receptors in the paraventricular nucleus in female rats.
Tsukamura H; Nagatani S; Cagampang FR; Kawakami S; Maeda K
Endocrinology; 1994 Mar; 134(3):1460-6. PubMed ID: 8119187
[TBL] [Abstract][Full Text] [Related]
4. Effects of corticotropin-releasing factor on energy balance in rats are sex dependent.
Rivest S; Deshaies Y; Richard D
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1417-22. PubMed ID: 2604001
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the medial preoptic area in the anorectic action of estrogens.
Dagnault A; Richard D
Am J Physiol; 1997 Jan; 272(1 Pt 2):R311-7. PubMed ID: 9039023
[TBL] [Abstract][Full Text] [Related]
7. Central activation of thermogenesis by prostaglandins: dependence on CRF.
Rothwell NJ
Horm Metab Res; 1990 Dec; 22(12):616-8. PubMed ID: 2076859
[TBL] [Abstract][Full Text] [Related]
8. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
Mansi JA; Rivest S; Drolet G
Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
[TBL] [Abstract][Full Text] [Related]
9. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.
Smagin GN; Howell LA; Ryan DH; De Souza EB; Harris RB
Neuroreport; 1998 May; 9(7):1601-6. PubMed ID: 9631473
[TBL] [Abstract][Full Text] [Related]
10. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
Dunn AJ; Antoon M; Chapman Y
Brain Res Bull; 1991 Apr; 26(4):539-42. PubMed ID: 1868353
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the catecholaminergic input to the paraventricular nucleus and of corticotropin-releasing hormone in the fasting-induced suppression of luteinizing hormone release in female rats.
Maeda K; Cagampang FR; Coen CW; Tsukamura H
Endocrinology; 1994 Apr; 134(4):1718-22. PubMed ID: 8137735
[TBL] [Abstract][Full Text] [Related]
12. Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats.
Arase K; Shargill NS; Bray GA
Am J Physiol; 1989 Mar; 256(3 Pt 2):R751-6. PubMed ID: 2784291
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.
Krahn DD; Gosnell BA; Levine AS; Morley JE
Brain Res; 1988 Mar; 443(1-2):63-9. PubMed ID: 2834018
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
[TBL] [Abstract][Full Text] [Related]
15. Dorsomedial hypothalamic corticotropin-releasing factor mediation of exercise-induced anorexia.
Kawaguchi M; Scott KA; Moran TH; Bi S
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1800-5. PubMed ID: 15677523
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor and schedule-induced polydipsia.
Cole BJ; Koob GF
Pharmacol Biochem Behav; 1994 Mar; 47(3):393-8. PubMed ID: 8208756
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
18. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
[TBL] [Abstract][Full Text] [Related]
19. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses to exercise in the rat: role of corticotropin-releasing factor.
Kregel KC; Overton JM; Seals DR; Tipton CM; Fisher LA
J Appl Physiol (1985); 1990 Feb; 68(2):561-7. PubMed ID: 2318769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
